TGen to Use GE Healthcare’s IN Cell Analyzer for Cancer Research
NEW YORK (GenomeWeb News) - GE Healthcare said today that it has entered into a strategic alliance with the Translational Genomics Research Institute in which TGen will apply its IN Cell Analyzer 1000 and 3000 to cancer research.
"This collaboration could result in a better understanding of the biological mechanisms involved in oncology, many of which are not currently well understood by the medical community," said Spyro Mousses, director of pharmaceutical genomics and cancer drug development at TGen, in a statement.
TGen expects to use GE's cellular imaging systems to observe cellular morphology and perform cytometry. "Most importantly, we can more accurately collect multi-parametric information about how cells are responding to specific genetic perturbations and to specific drug exposures," Mousses said.
Financial terms of the agreement were not disclosed.